Real-world clinical data analytics company Verana Health scooped up $150 million in Series E funding.
The round was led by Johnson & Johnson Innovation and Novo Growth, with participation from GV, Casdin Capital, Brook Byers, Merck Global Health Innovation Fund, THVC and Breyer Capital. Verana plans to use the influx of capital to expand its life sciences products across the drug development...
